Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7399 p523
6 May 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Independent pharmacist prescribing becomes legal, but no training courses are available yet

Pharmacist prescribers

Prospective pharmacist prescribers will need to retrain

Pharmacists were given the legislative go-ahead to prescribe independently this week. However the first prescribers are not likely to qualify until the end of the year.

Qualified pharmacist and nurse independent prescribers in England have been allowed to prescribe any licensed medicine for any condition within their competence (with the exception of all Controlled Drugs for pharmacists) from 1 May. Work to bring about legislative changes in Scotland and Wales is currently under way.

The Royal Pharmaceutical Society confirmed that work on the curriculum for independent prescribing has begun, but it is not expected to be available until later this year.

There are currently 555 pharmacist supplementary prescribers in England (224 in Scotland, 49 in Wales and eight overseas). To become independent prescribers they will need to undertake a conversion course.

Commenting on the DoH announcement, Hemant Patel, President of the Society, said: “This is perhaps the most significant professional development opportunity for pharmacists that we have seen in a generation. Ten years ago, in the Pharmacy in a new age strategy, the profession said that it wanted to be able to prescribe independently in a wide range of circumstances. Ever since, the Society has been working to make that patient-focused ambition a reality.

“Now, the Society will be working hard to ensure that pharmacists take up the great opportunities that independent prescribing offers. Already supplementary prescribing is transforming the way that patients experience the benefit of pharmacists’ skills. Now, the independent pharmacist prescriber will redefine the patient’s experience of our profession at the clinical frontline. This is a golden opportunity for pharmacists to demonstrate what they can do.”

Back to Top


©The Pharmaceutical Journal